Carnitine Responsive Migraine Headache Syndrome: Case Report and Review of the Literature.
Carnitine
Chronic daily headache
Chronic migraine
Headache
Intractable migraine
Mitochondria
Journal
Current pain and headache reports
ISSN: 1534-3081
Titre abrégé: Curr Pain Headache Rep
Pays: United States
ID NLM: 100970666
Informations de publication
Date de publication:
23 Mar 2021
23 Mar 2021
Historique:
accepted:
19
01
2021
entrez:
23
3
2021
pubmed:
24
3
2021
medline:
30
11
2021
Statut:
epublish
Résumé
To review carnitine's role in migraine and headache, present a case of a patient with intractable chronic migraine refractory to medications but exquisitely responsive to mitochondrial cofactors with a particularly prompt response to L-carnitine supplementation with dose response, and suggest scenarios where L-carnitine could be considered for prophylactic treatment in migraine and intractable headache with migraine features. Multiple treatments modalities are used to treat migraine, including nutraceutical therapies. Mitochondrial supplements are often used to treat migraine, based on controlled trials. One of the nutraceutical therapies used in neurological and non-neurological conditions is L-carnitine. A few studies have examined the effect of carnitine in patients with migraine. We present a case of a patient with chronic migraine-like headaches found to have carnitine deficiency whose headaches greatly improved with carnitine supplementation. This case suggests that secondary carnitine deficiency may cause chronic migraine. Energy deficiency states occur with migraine, and replenishment of energy substrates has demonstrated some improvement in migraine. Recent studies suggest that L-carnitine with other mitochondrial cofactors may be migraine preventives. The exact link between carnitine and migraine is unknown. Perhaps carnitine deficiency should be in the differential for refractory migraine. Supplementation with L-carnitine merits exploration as a nutraceutical treatment of chronic migraine. Our case suggests that there may be a dose-dependent response to L-carnitine.
Identifiants
pubmed: 33755806
doi: 10.1007/s11916-021-00936-5
pii: 10.1007/s11916-021-00936-5
doi:
Substances chimiques
Carnitine
S7UI8SM58A
Types de publication
Case Reports
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM